Medical Weight Loss for Elgin, Illinois Residents
Elgin, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Elgin through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Elgin Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Elgin, Illinois residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Elgin patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Patients across Elgin and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Illinois. We care for patients throughout Downtown and the greater Fox Valley area northwest of Chicago, with bilingual Spanish care. Every prescription for Elgin is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Our telehealth model serves Elgin and communities across Illinois with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Elgin patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Elgin patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Elgin
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Elgin address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Elgin
How do I get treatment from Elgin?
As a Elgin, Illinois patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Elgin?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Elgin in cold-pack packaging, no lines and no drive.
How much does it cost for Elgin patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Elgin do you serve?
We serve patients from across Elgin by telehealth, including Downtown and the greater Fox Valley area northwest of Chicago, with bilingual Spanish care.
How is medication shipped to Elgin patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Elgin address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elgin, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.